The ACME Laboratories Ltd. (DSE:ACMELAB)
Bangladesh · Delayed Price · Currency is BDT 84.30
+0.10 (0.12%)
At close: Jul 6, 2026
The ACME Laboratories Market Cap
The ACME Laboratories has a market cap or net worth of 17.82 billion as of July 6, 2026. Its market cap has increased by 22.56% in one year.
Market Cap
17.82B
Enterprise Value
37.77B
Revenue
40.05B
Ranking
n/a
PE Ratio
6.68
Stock Price
84.30
Market Cap Chart
Since June 8, 2016, The ACME Laboratories's market cap has decreased from 23.61B to 17.82B, a decrease of -24.55%. That is a compound annual growth rate of -2.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 6, 2026 | 17.84B | 18.90% |
| Dec 30, 2025 | 15.00B | -5.59% |
| Dec 30, 2024 | 15.89B | -11.65% |
| Dec 28, 2023 | 17.99B | - |
| Dec 29, 2022 | 17.99B | -1.73% |
| Dec 30, 2021 | 18.30B | 15.80% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Beximco Pharmaceuticals PLC. | 64.82B |
| Renata | 52.35B |
| Unilever Consumer Care | 39.88B |
| Beacon Pharmaceuticals | 25.69B |
| Asiatic Laboratories | 16.34B |
| The IBN SINA Pharmaceutical Industry | 9.91B |
| Navana Pharmaceuticals | 7.69B |
| Orion Pharma | 6.62B |